Monica Gandhi, MD, MPH, infectious disease doctor and director of the Center for AIDS Research at University of California–San Francisco, discusses medication therapies in the pipeline that could change the...
Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing pre-exposure prophylaxis to uninfected...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.
In this video, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the under-utilization of HIV pre-exposure prophylaxis (PrEP) and the integral role primary care providers play in screening and identifying...
In this Editorial, Shobha Swaminathan, MD, writes about the shift from desperation and fear regarding HIV/AIDS in the 1980s to optimism and hope today.
In this video, Jeffrey Kwong, DNP, MPH, ANP-BC, provides a preview of his session "Preventing HIV: Strategies for Primary Care Clinicians" at our Practical Updates in Primary Care 2022 Virtual Series from...
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine implementation...
Kathleen Ryan, PhD, answered our questions about her study, which indicated that rapid scale-up of PrEP was possible without the consequence of reduced HIV testing among Australian gay, bisexual, and other...
